The Company Management Department of the SSE STAR Market has officially issued a regulatory caution to Shenzhen Injoinic Technology Co., Ltd., along with its pertinent responsible individuals. On January 6, 2026, Injoinic Technology announced on the SSE E-Interaction platform that it had made a foray into the brain-computer interface chip sector by introducing the IPA1299 chip. This chip, as claimed, was applicable in scenarios related to brain-computer interfaces and had already commenced mass production and shipment. Following prompts from the SSE, the company released a clarification notice on January 7, elucidating that the product had been developed in collaboration with a shareholding entity and was still in the market cultivation phase. It further clarified that no large-scale sales had been realized yet, and consequently, there was no significant impact on the company's performance at that juncture. Moreover, the company pointed out that there were discrepancies in the technical pathways between its application domain and international invasive brain-computer interfaces, and the future sales prospects remained uncertain. Nevertheless, the company's stock price witnessed a 4.51% surge on that particular day. Owing to the inaccurate and incomplete disclosure of information on the E-Interaction platform, coupled with inadequate risk warnings, the SSE opted to issue a regulatory caution to Injoinic Technology and its then board secretary, Wu Renchao.